Business
AI in Life Sciences Market, 2026-2040 Industry Trends and Global Forecasts - IBM, IQVIA and Oracle Lead Data Platforms While Roche, Pfizer and AI Startups Accelerate Drug Discovery Innovation
AI in life sciences presents key opportunities in drug discovery, personalized medicine, and diagnostics by leveraging vast datasets for precise, cost-effective solutions. Growth is driven by increased data, demand for precision therapies, and partnerships with tech leaders, despite challenges in costs and regulation. AI in Life Sciences Market AI in Life Sciences Market Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "AI in Life Sciences Market, till 2040: Distribution by Deployment Mode, Type o
About this update from Roche Holding Ltd
[{"type":"image","alt":"Company Logo","displaySize":"","headline":null,"caption":"Company Logo","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":36,"url":"https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/g_3H8YP5.WdAX5cBtX03VA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTUwO2NmPXdlYnA-/https://media.zenfs.com/en/globenewswire.com/6a90a26a88cc04ec0d3fe15e0ab1be65","width":300,"height":36}},"lazy":false},{"type":"text","content":"AI in life sciences presents key opportunities in drug discovery, personalized medicine, and diagnostics by leveraging vast datasets for precise, cost-effective solutions. Growth is driven by increased data, demand for precision therapies, and partnerships with tech leaders, despite challenges in costs and regulation.","length":319,"tagName":"p"},{"type":"text","content":"AI in Life Sciences Market","length":26,"tagName":"p"},{"type":"image","alt":"AI in Life Sciences Market","displaySize":"","headline":null,"caption":"AI in Life Sciences Market","credit":"GlobeNewswire Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":600,"height":400,"url":"https://media.zenfs.com/en/globenewswire.com/b252f2c6f1b721aa9f0e5facf729cfec"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/N1HDeN14xt2cSNWlVpwfnQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTY0MDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/b252f2c6f1b721aa9f0e5facf729cfec","width":600,"height":400}}},{"type":"text","content":"Dublin, March 13, 2026 (GLOBE NEWSWIRE) -- The "AI in Life Sciences Market, till 2040: Distribution by Deployment Mode, Type of Offering, Type of Technology, Application Areas and Key Geographical Regions: Industry Trends and Global Forecasts" report has been added to ResearchAndMarkets.com's offering.The global Artificial intelligence in life sciences market size is estimated to grow from USD 5.69 billion in current year to USD 73.05 billion by 2040, at a CAGR of 20% during the forecast period, till 2040. Artificial intelligence (AI) is revolutionizing the life sciences sector, encompassing disciplines such as biology, pharmaceuticals, biotechnology, and medicine. These fields focus on advancing human health through the study of biological systems and therapeutic innovations. AI functions as an advanced computati...